Introduction Shwachman–Diamond syndrome (SDS) is a rare autosomal recessive disorder characterized by pancreatic exocrine insufficiency, immune deficiency, bone marrow failure and bone malformations. Systematic data concerning endocrine function in SDS are limited. We studied patients diagnosed in The Children’s Memorial Health Institute in Warsaw, Poland, to assess the prevalence of various endocrinopathies. Material and Methods In the pilot study, retrospective data were collected for 5 patients with SDS. Subsequently, patients with SDS aged 3-16 years were recruited prospectively. In total, 19 patients with mutations in SBDS gene were studied. Data were collected on anthropometric measurements, systemic screening tests of pituitary, thyroid, adrenal, pancreatic and gonadal function as well as bone mineral density. Descriptive statistics were tabulated and group differences assessed. Results Twelve patients (63%) had ≥ one endocrine disorder, including growth hormone dysfunction (ten patients, 53%), hypothyroidism (two patients, 10%), congenital hypopituitarism (one patient, 5%), and/or type 1 diabetes (one patient, 5%). The group of boys presented with a significantly lower height (-2.1 SD, p<0.0001) and BMI (-1.0 SD, p<0.00001). The group of girls also showed significantly lower height (-2.6 SD, p<0.00001) and BMI (-0.7 SD, p<0.0001). All patients had significantly lower height than their mid-parental height. Delayed bone age was found in 15 patients (84%) and osteopenia in 12 of 15 patients (80%). Conclusions Endocrine dysfunctions are common in SDS, especially growth hormone deficiency. Children with poor growth can benefit from an endocrinological evaluation and tests for GH deficiency. Bone mineral density measurements should be a part of a routine screening. Longitudinal studies are needed to better understand the etiology and true prevalence of these disorders. Introduction Shwachman–Diamond syndrome (SDS) is a rare autosomal recessive disorder characterized by pancreatic exocrine insufficiency, immune deficiency, bone marrow failure and bone malformations. Systematic data concerning endocrine function in SDS are limited. We studied patients diagnosed in The Children’s Memorial Health Institute in Warsaw, Poland, to assess the prevalence of various endocrinopathies. Material and Methods In the pilot study, retrospective data were collected for 5 patients with SDS. Subsequently, patients with SDS aged 3-16 years were recruited prospectively. In total, 19 patients with mutations in SBDS gene were studied. Data were collected on anthropometric measurements, systemic screening tests of pituitary, thyroid, adrenal, pancreatic and gonadal function as well as bone mineral density. Descriptive statistics were tabulated and group differences assessed. Results Twelve patients (63%) had ≥ one endocrine disorder, including growth hormone dysfunction (ten patients, 53%), hypothyroidism (two patients, 10%), congenital hypopituitarism (one patient, 5%), and/or type 1 diabetes (one patient, 5%). The group of boys presented with a significantly lower height (-2.1 SD, p<0.0001) and BMI (-1.0 SD, p<0.00001). The group of girls also showed significantly lower height (-2.6 SD, p<0.00001) and BMI (-0.7 SD, p<0.0001). All patients had significantly lower height than their mid-parental height. Delayed bone age was found in 15 patients (84%) and osteopenia in 12 of 15 patients (80%). Conclusions Endocrine dysfunctions are common in SDS, especially growth hormone deficiency. Children with poor growth can benefit from an endocrinological evaluation and tests for GH deficiency. Bone mineral density measurements should be a part of a routine screening. Longitudinal studies are needed to better understand the etiology and true prevalence of these disorders.